Publications

1. Amarasinghe GK, Arechiga Ceballos NG, Banyard AC, Basler CF, Bavari S, Bennett AJ, Blasdell KR, Briese T, Bukreyev A, Cai Y, Calisher CH, Campos Lawson C, Chandran K, Chapman CA, Chiu CY, Choi KS, Collins PL, Dietzgen RG, Dolja VV, Dolnik O, Domier LL, Durrwald R, Dye JM, Easton AJ, Ebihara H, Echevarria JE, Fooks AR, Formenty PBH, Fouchier RAM, Freuling CM, Ghedin E, Goldberg TL, Hewson R, Horie M, Hyndman TH, Jiang D, Kityo R, Kobinger GP, Kondo H, Koonin EV, Krupovic M, Kurath G, Lamb RA, Lee B, Leroy EM, Maes P, Maisner A, Marston DA, Mor SK, Muller T, Muhlberger E, Ramirez VMN, Netesov SV, Ng TFF, Nowotny N, Palacios G, Patterson JL, Paweska JT, Payne SL, Prieto K, Rima BK, Rota P, Rubbenstroth D, Schwemmle M, Siddell S, Smither SJ, Song Q, Song T, Stenglein MD, Stone DM, Takada A, Tesh RB, Thomazelli LM, Tomonaga K, Tordo N, Towner JS, Vasilakis N, Vazquez-Moron S, Verdugo C, Volchkov VE, Wahl V, Walker PJ, Wang D, Wang LF, Wellehan JFX, Wiley MR, Whitfield AE, Wolf YI, Ye G, Zhang YZ, Kuhn JH. Taxonomy of the order Mononegavirales: update 2018. Arch Virol. 2018 Apr 11 [Epub ahead of print]
   View PubMed
2. Wong G, Cao WG, He SH, Zhang ZR, Zhu WJ, Moffat E, Ebihara H, Embury-Hyatt C, Qiu XG. Development and characterization of a guinea pig model for Marburg virus. Zool Res. 2018 Jan 18; 39 (1):32-41
   View PubMed
3. Nelson EV, Pacheco JR, Hume AJ, Cressey TN, Deflube LR, Ruedas JB, Connor JH, Ebihara H, Muhlberger E. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening. Antiviral Res. 2017 Oct; 146:21-27 Epub 2017 Aug 12
   View PubMed
4. Banadyga L, Hoenen T, Ambroggio X, Dunham E, Groseth A, Ebihara H. Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging. Sci Rep. 2017 Aug 09; 7 (1):7698
   View PubMed
5. Amarasinghe GK, Bao Y, Basler CF, Bavari S, Beer M, Bejerman N, Blasdell KR, Bochnowski A, Briese T, Bukreyev A, Calisher CH, Chandran K, Collins PL, Dietzgen RG, Dolnik O, Durrwald R, Dye JM, Easton AJ, Ebihara H, Fang Q, Formenty P, Fouchier RAM, Ghedin E, Harding RM, Hewson R, Higgins CM, Hong J, Horie M, James AP, Jiang D, Kobinger GP, Kondo H, Kurath G, Lamb RA, Lee B, Leroy EM, Li M, Maisner A, Muhlberger E, Netesov SV, Nowotny N, Patterson JL, Payne SL, Paweska JT, Pearson MN, Randall RE, Revill PA, Rima BK, Rota P, Rubbenstroth D, Schwemmle M, Smither SJ, Song Q, Stone DM, Takada A, Terregino C, Tesh RB, Tomonaga K, Tordo N, Towner JS, Vasilakis N, Volchkov VE, Wahl-Jensen V, Walker PJ, Wang B, Wang D, Wang F, Wang LF, Werren JH, Whitfield AE, Yan Z, Ye G, Kuhn JH. Taxonomy of the order Mononegavirales: update 2017. Arch Virol. 2017 Aug; 162 (8):2493-2504 Epub 2017 Apr 07
   View PubMed
6. Groseth A, Vine V, Weisend C, Guevara C, Watts D, Russell B, Tesh RB, Ebihara H. Maguari Virus Associated with Human Disease. Emerg Infect Dis. 2017 Aug; 23 (8):1325-1331
   View PubMed
7. Olejnik J, Forero A, Deflube LR, Hume AJ, Manhart WA, Nishida A, Marzi A, Katze MG, Ebihara H, Rasmussen AL, Muhlberger E. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages. J Virol. 2017 Jun 01; 91: (11).
   View PubMed
8. Matsuno K, Orba Y, Maede-White K, Scott D, Feldmann F, Liang M, Ebihara H. Animal Models of Emerging Tick-Borne Phleboviruses: Determining Target Cells in a Lethal Model of SFTSV Infection. Front Microbiol. 2017; 8:104.
   View PubMed
9. Banadyga L, Ebihara H. Quantification of RNA Content in Reconstituted Ebola Virus Nucleocapsids by Immunoprecipitation. Methods Mol Biol. 2017; 1628:93-107
   View PubMed
10. Yamaoka S, Banadyga L, Bray M, Ebihara H. Small Animal Models for Studying Filovirus Pathogenesis. Curr Top Microbiol Immunol. 2017; 411:195-227
    View PubMed
11. Marzi A, Banadyga L, Haddock E, Thomas T, Shen K, Horne EJ, Scott DP, Feldmann H, Ebihara H. A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever. Sci Rep. 2016 Dec 15; 6:39214.
    View PubMed
12. Yamaoka S, Ebihara H. The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis. Virulence. 2016 Nov 16; 7: (8)856-859.
    View PubMed
13. de Wit E, Rosenke K, Fischer RJ, Marzi A, Prescott J, Bushmaker T, van Doremalen N, Emery SL, Falzarano D, Feldmann F, Groseth A, Hoenen T, Juma B, McNally KL, Ochieng M, Omballa V, Onyango CO, Owuor C, Rowe T, Safronetz D, Self J, Williamson BN, Zemtsova G, Grolla A, Kobinger G, Rayfield M, Stroher U, Strong JE, Best SM, Ebihara H, Zoon KC, Nichol ST, Nyenswah TG, Bolay FK, Massaquoi M, Feldmann H, Fields B. Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015. J Infect Dis. 2016 Oct 15; 214: (suppl 3)S169-S176.
    View PubMed
14. de Wit E, Kramer S, Prescott J, Rosenke K, Falzarano D, Marzi A, Fischer RJ, Safronetz D, Hoenen T, Groseth A, van Doremalen N, Bushmaker T, McNally KL, Feldmann F, Williamson BN, Best SM, Ebihara H, Damiani IA, Adamson B, Zoon KC, Nyenswah TG, Bolay FK, Massaquoi M, Sprecher A, Feldmann H, Munster VJ. Clinical Chemistry of Patients With Ebola in Monrovia, Liberia. J Infect Dis. 2016 Oct 15; 214: (suppl 3)S303-S307.
    View PubMed
15. Chiramel AI, Banadyga L, Dougherty JD, Falzarano D, Martellaro C, Brees D, Taylor RT, Ebihara H, Best SM. Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga. J Infect Dis. 2016 Oct 15; 214: (suppl 3)S355-S359.
    View PubMed
16. Okada K, Ito N, Yamaoka S, Masatani T, Ebihara H, Goto H, Nakagawa K, Mitake H, Okadera K, Sugiyama M. Roles of the Rabies Virus Phosphoprotein Isoforms in Pathogenesis. J Virol. 2016 Sep 15; 90: (18)8226-37.
    View PubMed
17. Banadyga L, Dolan MA, Ebihara H. Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis. J Mol Biol. 2016 Aug 28; 428: (17)3449-66.
    View PubMed
18. Afonso CL, Amarasinghe GK, Banyai K, Bao Y, Basler CF, Bavari S, Bejerman N, Blasdell KR, Briand FX, Briese T, Bukreyev A, Calisher CH, Chandran K, Cheng J, Clawson AN, Collins PL, Dietzgen RG, Dolnik O, Domier LL, Durrwald R, Dye JM, Easton AJ, Ebihara H, Farkas SL, Freitas-Astua J, Formenty P, Fouchier RA, Fu Y, Ghedin E, Goodin MM, Hewson R, Horie M, Hyndman TH, Jiang D, Kitajima EW, Kobinger GP, Kondo H, Kurath G, Lamb RA, Lenardon S, Leroy EM, Li CX, Lin XD, Liu L, Longdon B, Marton S, Maisner A, Muhlberger E, Netesov SV, Nowotny N, Patterson JL, Payne SL, Paweska JT, Randall RE, Rima BK, Rota P, Rubbenstroth D, Schwemmle M, Shi M, Smither SJ, Stenglein MD, Stone DM, Takada A, Terregino C, Tesh RB, Tian JH, Tomonaga K, Tordo N, Towner JS, Vasilakis N, Verbeek M, Volchkov VE, Wahl-Jensen V, Walsh JA, Walker PJ, Wang D, Wang LF, Wetzel T, Whitfield AE, Xie JT, Yuen KY, Zhang YZ, Kuhn JH. Taxonomy of the order Mononegavirales: update 2016. Arch Virol. 2016 Aug; 161: (8)2351-60.
    View PubMed
19. Hardcastle K, Scott D, Safronetz D, Brining DL, Ebihara H, Feldmann H, LaCasse RA. Laguna Negra Virus Infection Causes Hantavirus Pulmonary Syndrome in Turkish Hamsters (Mesocricetus brandti). Vet Pathol. 2016 Jan; 53: (1)182-9.
    View PubMed
20. Tsuda Y, Hoenen T, Banadyga L, Weisend C, Ricklefs SM, Porcella SF, Ebihara H. An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity. J Infect Dis. 2015 Oct 01; 212 Suppl 2:S129-37.
    View PubMed
21. Hoenen T, Marzi A, Scott DP, Feldmann F, Callison J, Safronetz D, Ebihara H, Feldmann H. Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. J Infect Dis. 2015 Oct 01; 212 Suppl 2:S242-6.
    View PubMed
22. Wong G, Qiu X, Ebihara H, Feldmann H, Kobinger GP. Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice. J Infect Dis. 2015 Oct 01; 212 Suppl 2:S435-42.
    View PubMed
23. Cross RW, Fenton KA, Geisbert JB, Ebihara H, Mire CE, Geisbert TW. Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model. J Infect Dis. 2015 Oct 01; 212 Suppl 2:S258-70.
    View PubMed
24. Gabriel G, Feldmann F, Reimer R, Thiele S, Fischer M, Hartmann E, Bader M, Ebihara H, Hoenen T, Feldmann H. Importin-alpha7 Is Involved in the Formation of Ebola Virus Inclusion Bodies but Is Not Essential for Pathogenicity in Mice. J Infect Dis. 2015 Oct 01; 212 Suppl 2:S316-21.
    View PubMed
25. Groseth A, Vine V, Weisend C, Ebihara H. Complete genome sequence of trivittatus virus. Arch Virol. 2015 Oct; 160: (10)2637-9.
    View PubMed
26. Pinto AK, Williams GD, Szretter KJ, White JP, Proenca-Modena JL, Liu G, Olejnik J, Brien JD, Ebihara H, Muhlberger E, Amarasinghe G, Diamond MS, Boon AC. Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae Families. J Virol. 2015 Sep; 89: (18)9465-76.
    View PubMed
27. Dunham EC, Banadyga L, Groseth A, Chiramel AI, Best SM, Ebihara H, Feldmann H, Hoenen T. Assessing the contribution of interferon antagonism to the virulence of West African Ebola viruses. Nat Commun. 2015 Aug 05; 6:8000.
    View PubMed
28. Hontz RD, Guevara C, Halsey ES, Silvas J, Santiago FW, Widen SG, Wood TG, Casanova W, Vasilakis N, Watts DM, Kochel TJ, Ebihara H, Aguilar PV. Itaya virus, a Novel Orthobunyavirus Associated with Human Febrile Illness, Peru. Emerg Infect Dis. 2015 May; 21: (5)781-8.
    View PubMed
29. Hoenen T, Safronetz D, Groseth A, Wollenberg KR, Koita OA, Diarra B, Fall IS, Haidara FC, Diallo F, Sanogo M, Sarro YS, Kone A, Togo AC, Traore A, Kodio M, Dosseh A, Rosenke K, de Wit E, Feldmann F, Ebihara H, Munster VJ, Zoon KC, Feldmann H, Sow S. Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences. Science. 2015 Apr 03; 348: (6230)117-9.
    View PubMed
30. Groseth A, Wollenberg KR, Mampilli V, Shupert T, Weisend C, Guevara C, Kochel TJ, Tesh RB, Ebihara H. Spatiotemporal analysis of Guaroa virus diversity, evolution, and spread in South America. Emerg Infect Dis. 2015 Mar; 21: (3)460-3.
    View PubMed
31. Matsuno K, Weisend C, Kajihara M, Matysiak C, Williamson BN, Simuunza M, Mweene AS, Takada A, Tesh RB, Ebihara H. Comprehensive molecular detection of tick-borne phleboviruses leads to the retrospective identification of taxonomically unassigned bunyaviruses and the discovery of a novel member of the genus phlebovirus. J Virol. 2015 Jan; 89: (1)594-604.
    View PubMed
32. Hoenen T, Groseth A, Feldmann F, Marzi A, Ebihara H, Kobinger G, Gunther S, Feldmann H. Complete genome sequences of three ebola virus isolates from the 2014 outbreak in west Africa. Genome Announc. 2014 Dec 18; 2: (6).
    View PubMed
33. Brauburger K, Boehmann Y, Tsuda Y, Hoenen T, Olejnik J, Schumann M, Ebihara H, Muhlberger E. Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation. J Virol. 2014 Nov; 88: (21)12558-71.
    View PubMed
34. Watt A, Moukambi F, Banadyga L, Groseth A, Callison J, Herwig A, Ebihara H, Feldmann H, Hoenen T. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity. J Virol. 2014 Sep; 88: (18)10511-24.
    View PubMed
35. Groseth A, Mampilli V, Weisend C, Dahlstrom E, Porcella SF, Russell BJ, Tesh RB, Ebihara H. Molecular characterization of human pathogenic bunyaviruses of the Nyando and BwambaPongola virus groups leads to the genetic identification of Mojui dos Campos and Kaeng Khoi virus. PLoS Negl Trop Dis. 2014 Sep; 8: (9)e3147.
    View PubMed
36. Safronetz D, Prescott J, Feldmann F, Haddock E, Rosenke R, Okumura A, Brining D, Dahlstrom E, Porcella SF, Ebihara H, Scott DP, Hjelle B, Feldmann H. Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques. Proc Natl Acad Sci U S A. 2014 May 13; 111: (19)7114-9.
    View PubMed
37. Bukreyev AA, Chandran K, Dolnik O, Dye JM, Ebihara H, Leroy EM, Muhlberger E, Netesov SV, Patterson JL, Paweska JT, Saphire EO, Smither SJ, Takada A, Towner JS, Volchkov VE, Warren TK, Kuhn JH. Discussions and decisions of the 2012-2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012-June 2013. Arch Virol. 2014 Apr; 159: (4)821-30.
    View PubMed
38. Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe. 2013 Jul 17; 14: (1)74-84.
    View PubMed
39. Zivcec M, Safronetz D, Scott D, Robertson S, Ebihara H, Feldmann H. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon alphabeta receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. J Infect Dis. 2013 Jun 15; 207: (12)1909-21.
    View PubMed
40. Olejnik J, Alonso J, Schmidt KM, Yan Z, Wang W, Marzi A, Ebihara H, Yang J, Patterson JL, Ryabchikova E, Muhlberger E. Ebola virus does not block apoptotic signaling pathways. J Virol. 2013 May; 87: (10)5384-96.
    View PubMed
41. Safronetz D, Prescott J, Haddock E, Scott DP, Feldmann H, Ebihara H. Hamster-adapted Sin Nombre virus causes disseminated infection and efficiently replicates in pulmonary endothelial cells without signs of disease. J Virol. 2013 Apr; 87: (8)4778-82.
    View PubMed
42. Wolff S, Ebihara H, Groseth A. Arenavirus budding: a common pathway with mechanistic differences. Viruses. 2013 Jan 31; 5: (2)528-49.
    View PubMed
43. Ebihara H, Zivcec M, Gardner D, Falzarano D, LaCasse R, Rosenke R, Long D, Haddock E, Fischer E, Kawaoka Y, Feldmann H. A Syrian golden hamster model recapitulating ebola hemorrhagic fever. J Infect Dis. 2013 Jan 15; 207: (2)306-18.
    View PubMed
44. Mehedi M, Hoenen T, Robertson S, Ricklefs S, Dolan MA, Taylor T, Falzarano D, Ebihara H, Porcella SF, Feldmann H. Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure. PLoS Pathog. 2013; 9: (10)e1003677.
    View PubMed
45. Wahl-Jensen V, Bollinger L, Safronetz D, de Kok-Mercado F, Scott DP, Ebihara H. Use of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers. Viruses. 2012 Dec 14; 4: (12)3754-84.
    View PubMed
46. Groseth A, Matsuno K, Dahlstrom E, Anzick SL, Porcella SF, Ebihara H. Complete genome sequencing of four geographically diverse strains of Batai virus. J Virol. 2012 Dec; 86: (24)13844-5.
    View PubMed
47. Groseth A, Weisend C, Ebihara H. Complete genome sequencing of mosquito and human isolates of Ngari virus. J Virol. 2012 Dec; 86: (24)13846-7.
    View PubMed
48. Brown KS, Ebihara H, Feldmann H. Development of a minigenome system for Andes virus, a New World hantavirus. Arch Virol. 2012 Nov; 157: (11)2227-33.
    View PubMed
49. Safronetz D, Ebihara H, Feldmann H, Hooper JW. The Syrian hamster model of hantavirus pulmonary syndrome. Antiviral Res. 2012 Sep; 95: (3)282-92.
    View PubMed
50. Shimojima M, Stroher U, Ebihara H, Feldmann H, Kawaoka Y. Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry. J Virol. 2012 Feb; 86: (4)2067-78.
    View PubMed
51. Groseth A, Marzi A, Hoenen T, Herwig A, Gardner D, Becker S, Ebihara H, Feldmann H. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog. 2012; 8: (8)e1002847.
    View PubMed
52. Brown KS, Safronetz D, Marzi A, Ebihara H, Feldmann H. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus. J Virol. 2011 Dec; 85: (23)12781-91.
    View PubMed
53. Safronetz D, Zivcec M, Lacasse R, Feldmann F, Rosenke R, Long D, Haddock E, Brining D, Gardner D, Feldmann H, Ebihara H. Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus. PLoS Pathog. 2011 Dec; 7: (12)e1002426.
    View PubMed
54. Marzi A, Ebihara H, Callison J, Groseth A, Williams KJ, Geisbert TW, Feldmann H. Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J Infect Dis. 2011 Nov; 204 Suppl 3:S1066-74.
    View PubMed
55. Falzarano D, Feldmann F, Grolla A, Leung A, Ebihara H, Strong JE, Marzi A, Takada A, Jones S, Gren J, Geisbert J, Jones S, Geisbert TW, Feldmann H. Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus. J Infect Dis. 2011 Nov; 204 Suppl 3:S1082-9.
    View PubMed
56. Tsuda Y, Safronetz D, Brown K, LaCasse R, Marzi A, Ebihara H, Feldmann H. Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection. J Infect Dis. 2011 Nov; 204 Suppl 3:S1090-7.
    View PubMed
57. Ebihara H, Rockx B, Marzi A, Feldmann F, Haddock E, Brining D, LaCasse RA, Gardner D, Feldmann H. Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus. J Infect Dis. 2011 Nov; 204 Suppl 3:S991-9.
    View PubMed
58. Cilloniz C, Ebihara H, Ni C, Neumann G, Korth MJ, Kelly SM, Kawaoka Y, Feldmann H, Katze MG. Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J Virol. 2011 Sep; 85: (17)9060-8.
    View PubMed
59. Mehedi M, Groseth A, Feldmann H, Ebihara H. Clinical aspects of Marburg hemorrhagic fever. Future Virol. 2011 Sep; 6: (9)1091-1106.
    View PubMed
60. Rockx B, Brining D, Kramer J, Callison J, Ebihara H, Mansfield K, Feldmann H. Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection. J Virol. 2011 Aug; 85: (15)7658-71.
    View PubMed
61. Zivcec M, Safronetz D, Haddock E, Feldmann H, Ebihara H. Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus). J Immunol Methods. 2011 May 31; 368: (1-2)24-35.
    View PubMed
62. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, Gardner D, Proll SC, Marzi A, Tsuda Y, Lacasse RA, Kercher L, York A, Korth MJ, Long D, Rosenke R, Shupert WL, Aranda CA, Mattoon JS, Kobasa D, Kobinger G, Li Y, Taubenberger JK, Richt JA, Parnell M, Ebihara H, Kawaoka Y, Katze MG, Feldmann H. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol. 2011 Feb; 85: (3)1214-23.
    View PubMed
63. Ogawa H, Miyamoto H, Ebihara H, Ito K, Morikawa S, Feldmann H, Takada A. Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene. J Virol Methods. 2011 Jan; 171: (1)310-3.
    View PubMed
64. Safronetz D, Haddock E, Feldmann F, Ebihara H, Feldmann H. In vitro and in vivo activity of ribavirin against Andes virus infection. PLoS One. 2011; 6: (8)e23560.
    View PubMed
65. Matsuno K, Nakayama E, Noyori O, Marzi A, Ebihara H, Irimura T, Feldmann H, Takada A. C-type lectins do not act as functional receptors for filovirus entry into cells. Biochem Biophys Res Commun. 2010 Dec 03; 403: (1)144-8.
    View PubMed
66. Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y, Lipkin WI, Negredo AI, Netesov SV, Nichol ST, Palacios G, Peters CJ, Tenorio A, Volchkov VE, Jahrling PB. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol. 2010 Dec; 155: (12)2083-103.
    View PubMed
67. Levine JR, Prescott J, Brown KS, Best SM, Ebihara H, Feldmann H. Antagonism of type I interferon responses by new world hantaviruses. J Virol. 2010 Nov; 84: (22)11790-801.
    View PubMed
68. Safronetz D, Lopez JE, Sogoba N, Traore' SF, Raffel SJ, Fischer ER, Ebihara H, Branco L, Garry RF, Schwan TG, Feldmann H. Detection of Lassa virus, Mali. Emerg Infect Dis. 2010 Jul; 16: (7)1123-6.
    View PubMed
69. Prescott J, Hall P, Acuna-Retamar M, Ye C, Wathelet MG, Ebihara H, Feldmann H, Hjelle B. New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells. PLoS One. 2010 Jun 17; 5: (6)e11159.
    View PubMed
70. Koma T, Yoshimatsu K, Pini N, Safronetz D, Taruishi M, Levis S, Endo R, Shimizu K, Yasuda SP, Ebihara H, Feldmann H, Enria D, Arikawa J. Truncated hantavirus nucleocapsid proteins for serotyping Sin Nombre, Andes, and Laguna Negra hantavirus infections in humans and rodents. J Clin Microbiol. 2010 May; 48: (5)1635-42.
    View PubMed
71. Safronetz D, Hegde NR, Ebihara H, Denton M, Kobinger GP, St Jeor S, Feldmann H, Johnson DC. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. J Virol. 2009 Jul; 83: (14)7285-95.
    View PubMed
72. Halfmann P, Ebihara H, Marzi A, Hatta Y, Watanabe S, Suresh M, Neumann G, Feldmann H, Kawaoka Y. Replication-deficient ebolavirus as a vaccine candidate. J Virol. 2009 Apr; 83: (8)3810-5.
    View PubMed
73. Yamayoshi S, Noda T, Ebihara H, Goto H, Morikawa Y, Lukashevich IS, Neumann G, Feldmann H, Kawaoka Y. Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. Cell Host Microbe. 2008 Mar 13; 3: (3)168-77.
    View PubMed
74. Halfmann P, Kim JH, Ebihara H, Noda T, Neumann G, Feldmann H, Kawaoka Y. Generation of biologically contained Ebola viruses. Proc Natl Acad Sci U S A. 2008 Jan 29; 105: (4)1129-33.
    View PubMed
75. Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y. Epitopes required for antibody-dependent enhancement of Ebola virus infection. J Infect Dis. 2007 Nov 15; 196 Suppl 2:S347-56.
    View PubMed
76. Groseth A, Hoenen T, Alimonti JB, Zielecki F, Ebihara H, Theriault S, Stroher U, Becker S, Feldmann H. In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics. J Infect Dis. 2007 Nov 15; 196 Suppl 2:S382-9.
    View PubMed
77. Kurosaki Y, Takada A, Ebihara H, Grolla A, Kamo N, Feldmann H, Kawaoka Y, Yasuda J. Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification. J Virol Methods. 2007 Apr; 141: (1)78-83.
    View PubMed
78. Neumann G, Geisbert TW, Ebihara H, Geisbert JB, Daddario-DiCaprio KM, Feldmann H, Kawaoka Y. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. J Virol. 2007 Mar; 81: (6)2995-8.
    View PubMed
79. Takada A, Ebihara H, Jones S, Feldmann H, Kawaoka Y. Protective efficacy of neutralizing antibodies against Ebola virus infection. Vaccine. 2007 Jan 22; 25: (6)993-9.
    View PubMed
80. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M, Feldmann F, Alimonti JB, Fernando L, Li Y, Katze MG, Feldmann H, Kawaoka Y. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature. 2007 Jan 18; 445: (7125)319-23.
    View PubMed
81. Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, Jones S, Feldmann H, Kawaoka Y. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol. 2006 Oct; 80: (20)10109-16.
    View PubMed
82. Noda T, Ebihara H, Muramoto Y, Fujii K, Takada A, Sagara H, Kim JH, Kida H, Feldmann H, Kawaoka Y. Assembly and budding of Ebolavirus. PLoS Pathog. 2006 Sep; 2: (9)e99.
    View PubMed
83. Hoenen T, Groseth A, Kolesnikova L, Theriault S, Ebihara H, Hartlieb B, Bamberg S, Feldmann H, Stroher U, Becker S. Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol. 2006 Jul; 80: (14)7260-4.
    View PubMed
84. Ebihara H, Takada A, Kobasa D, Jones S, Neumann G, Theriault S, Bray M, Feldmann H, Kawaoka Y. Molecular determinants of Ebola virus virulence in mice. PLoS Pathog. 2006 Jul; 2: (7)e73.
    View PubMed
85. Neumann G, Ebihara H, Takada A, Noda T, Kobasa D, Jasenosky LD, Watanabe S, Kim JH, Feldmann H, Kawaoka Y. Ebola virus VP40 late domains are not essential for viral replication in cell culture. J Virol. 2005 Aug; 79: (16)10300-7.
    View PubMed
86. Ebihara H, Groseth A, Neumann G, Kawaoka Y, Feldmann H. The role of reverse genetics systems in studying viral hemorrhagic fevers. Thromb Haemost. 2005 Aug; 94: (2)240-53.
    View PubMed
87. Ogino M, Yoshimatsu K, Ebihara H, Araki K, Lee BH, Okumura M, Arikawa J. Cell fusion activities of Hantaan virus envelope glycoproteins. J Virol. 2004 Oct; 78: (19)10776-82.
    View PubMed
88. Takada A, Fujioka K, Tsuiji M, Morikawa A, Higashi N, Ebihara H, Kobasa D, Feldmann H, Irimura T, Kawaoka Y. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol. 2004 Mar; 78: (6)2943-7.
    View PubMed
89. Yoshimatsu K, Lee BH, Araki K, Morimatsu M, Ogino M, Ebihara H, Arikawa J. The multimerization of hantavirus nucleocapsid protein depends on type-specific epitopes. J Virol. 2003 Jan; 77: (2)943-52.
    View PubMed
90. Ogino M, Ebihara H, Lee BH, Araki K, Lundkvist A, Kawaoka Y, Yoshimatsu K, Arikawa J. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin Diagn Lab Immunol. 2003 Jan; 10: (1)154-60.
    View PubMed
91. Sugimoto C, Hasegawa M, Kato A, Zheng HY, Ebihara H, Taguchi F, Kitamura T, Yogo Y. Evolution of human Polyomavirus JC: implications for the population history of humans. J Mol Evol. 2002 Mar; 54: (3)285-97.
    View PubMed
92. Araki K, Yoshimatsu K, Ogino M, Ebihara H, Lundkvist A, Kariwa H, Takashima I, Arikawa J. Truncated hantavirus nucleocapsid proteins for serotyping Hantaan, Seoul, and Dobrava hantavirus infections. J Clin Microbiol. 2001 Jul; 39: (7)2397-404.
    View PubMed
93. Wang H, Yoshimatsu K, Ebihara H, Ogino M, Araki K, Kariwa H, Wang Z, Luo Z, Li D, Hang C, Arikawa J. Genetic diversity of hantaviruses isolated in china and characterization of novel hantaviruses isolated from Niviventer confucianus and Rattus rattus. Virology. 2000 Dec 20; 278: (2)332-45.
    View PubMed
94. Ebihara H, Yoshimatsu K, Ogino M, Araki K, Ami Y, Kariwa H, Takashima I, Li D, Arikawa J. Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence. J Virol. 2000 Oct; 74: (19)9245-55.
    View PubMed
95. Kariwa H, Yoshimatsu K, Araki K, Chayama K, Kumada H, Ogino M, Ebihara H, Murphy ME, Mizutani T, Takashima I, Arikawa J. Detection of hantaviral antibodies among patients with hepatitis of unknown etiology in Japan. Microbiol Immunol. 2000; 44: (5)357-62.
    View PubMed
96. Ogino M, Yoshimatsu K, Ebihara H, Arikawa J. N-acetylgalactosamine (GalNAc)-specific lectins mediate enhancement of Hantaan virus infection. Arch Virol. 1999; 144: (9)1765-77.
    View PubMed
97. Guo J, Sugimoto C, Kitamura T, Ebihara H, Kato A, Guo Z, Liu J, Zheng SP, Wang YL, Na YQ, Suzuki M, Taguchi F, Yogo Y. Four geographically distinct genotypes of JC virus are prevalent in China and Mongolia: implications for the racial composition of modern China. J Gen Virol. 1998 Oct; 79 ( Pt 10):2499-505.
    View PubMed
98. Kitamura T, Sugimoto C, Kato A, Ebihara H, Suzuki M, Taguchi F, Kawabe K, Yogo Y. Persistent JC virus (JCV) infection is demonstrated by continuous shedding of the same JCV strains. J Clin Microbiol. 1997 May; 35: (5)1255-7.
    View PubMed
99. Guo J, Kitamura T, Ebihara H, Sugimoto C, Kunitake T, Takehisa J, Na YQ, Al-Ahdal MN, Hallin A, Kawabe K, Taguchi F, Yogo Y. Geographical distribution of the human polyomavirus JC virus type A and B and isolation of a new type from Ghana. J Gen Virol. 1996 May; 77 ( Pt 5):919-27.
    View PubMed